"Pooled Analysis of Phase 3 studies of ADS-5102 (amantadine hydrochloride) extended release capsules for Levodopa-Induced Dyskinesia: A detailed review of UDysRS Results (S56.003)." Neurology
88.16 Supplement
(2017):
S56.003.
Web. 05 Feb. 2023.
Advertisement